Freda Lewis-Hall, M.D., DFAPA served as Senior Medical Advisor to the Chief Executive Officer at Pfizer until her retirement in March 2020. Prior to that, she was the Chief Patient Officer and Executive Vice President at Pfizer. In this role, Freda worked to extend the reach of Pfizer’s patient-facing health information and education and amplify the voice of the patient inside and outside Pfizer. From 2009-2018, Freda served as Pfizer’s Chief Medical Officer, responsible for the safe, effective and appropriate use of Pfizer medicines and vaccines, and in this role she reshaped Pfizer’s medical policies and practices to intensify the company’s focus on patient engagement and inclusion. Before joining Pfizer, Freda held senior leadership positions in medical affairs and product development with Vertex Pharmaceuticals, Bristol-Myers Squibb, Pharmacia and Eli Lilly and Company. Prior to joining the biopharmaceutical industry, she served as Vice Chairperson and Associate Professor in the Department of Psychiatry at Howard University College of Medicine and was an advisor to the National Institute of Mental Health. She graduated from Johns Hopkins University and earned her medical doctorate at Howard University College of Medicine. She launched her medical career as a practicing physician and then focused her academic research on the effects of health care disparities and the impact of mental illness on families and communities. Freda also currently serves as a member of the Board of Directors for 1Life HealthCare, Inc and Exact Sciences Corporation. Freda is a distinguished fellow of the American Psychiatric Association. She is a frequent speaker on issues such as improving patient safety and outcomes and reducing stigma and healthcare disparities. She appears regularly on health-related television programs in major global markets, including CBS-syndicated shows such as The Doctors and Dr. Phil. She also shares health and medical information through